HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Tomasz Świtaj Selected Research
Tomasz Świtaj Research Topics
Disease
9
Melanoma (Melanoma, Malignant)
05/2024 - 01/2015
5
Sarcoma (Soft Tissue Sarcoma)
12/2021 - 08/2014
3
Disease Progression
05/2024 - 01/2015
3
Perivascular Epithelioid Cell Neoplasms
01/2023 - 08/2014
2
Neoplasms (Cancer)
08/2022 - 08/2014
2
Neurofibrosarcoma (MPNST)
12/2020 - 09/2020
2
Alveolar Soft Part Sarcoma
05/2017 - 08/2014
1
Stomach Neoplasms (Stomach Cancer)
12/2021
1
Ewing Sarcoma (Sarcoma, Ewing)
08/2021
1
Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2021
1
Synovial Sarcoma (Synovioma)
09/2020
1
Dermatofibrosarcoma
08/2014
1
Giant Cell Tumor of Bone
08/2014
1
Clear Cell Sarcoma
08/2014
Drug/Important Bio-Agent (IBA)
2
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
09/2023 - 10/2018
1
pembrolizumab
IBA
09/2023
1
Nivolumab
IBA
09/2023
1
trametinib
IBA
09/2023
1
dabrafenib
IBA
09/2023
1
MTOR Inhibitors
IBA
01/2023
1
tributyl phosphate (TBP)
IBA
08/2022
1
Circulating Tumor DNA
IBA
02/2022
1
Sirolimus (Rapamycin)
FDA Link
08/2021
1
Imatinib Mesylate (Gleevec)
FDA Link
01/2021
1
Immune Checkpoint Inhibitors
IBA
10/2019
1
Sunitinib (Sutent)
FDA Link
05/2017
1
Vemurafenib
IBA
01/2015
Therapy/Procedure
12
Therapeutics
05/2024 - 08/2014
5
Drug Therapy (Chemotherapy)
01/2023 - 08/2014
4
Immunotherapy
05/2024 - 10/2019
3
Radiotherapy
08/2022 - 06/2021
1
Neoadjuvant Therapy
12/2021
1
Adjuvant Radiotherapy
06/2021